Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SFRP1 | Q8N474 | 2/20 | 0.67 |
| ▸ | HTR7 | P34969 | 8/20 | 0.57 |
| ▸ | HTR2A | P28223 | 3/20 | 0.52 |
| ▸ | HTR6 | P50406 | 3/20 | 0.52 |
| ▸ | HTR1A | P08908 | 2/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.50 |
| ▸ | CCR1 | P32246 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4798870 | 0.88 | SFRP1 (0.69) | SFRP1HTR7HTR1ASMN1; SMN2L3MBTL1 | |
| SCHEMBL4616665 | 0.87 | SFRP1 (0.65) | SFRP1HTR7HTR2AHTR6HTR1A | |
| SCHEMBL6103833 | 0.82 | KMT2A (0.59) | SFRP1SMN1; SMN2L3MBTL1KMT2AALDH1A1 | |
| SCHEMBL4617493 | 0.81 | SFRP1 (0.78) | SFRP1HTR7HTR1ASMN1; SMN2L3MBTL1 | |
| SCHEMBL4618852 | 0.81 | SFRP1 (1.00) | SFRP1HTR7HTR1AL3MBTL1MBTD1 | |
| SCHEMBL4616512 | 0.79 | SFRP1 (0.74) | SFRP1HTR7HTR2AHTR6HTR1A | |
| SCHEMBL4617959 | 0.79 | SFRP1 (0.56) | SFRP1HTR7HTR2AHTR1AHTR2C | |
| SCHEMBL4618720 | 0.78 | SFRP1 (0.73) | SFRP1HTR7L3MBTL1MBTD1CCR1 | |
| SCHEMBL4638749 | 0.78 | SFRP1 (0.66) | SFRP1SMN1; SMN2L3MBTL1KMT2AALDH1A1 | |
| SCHEMBL12672472 | 0.77 | HTR7 (0.83) | SFRP1HTR7HTR2AHTR6HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1879859-A2 | DIARYLSULFONE SULFONAMIDES AND USE THEROF | Wyeth a Corporation of the State of Delaware (US) | 2008-01-23 | — | — | EP | claimed |
| US-20060276464-A1 | Diarylsulfone sulfonamides and use thereof | WYETH (US) | 2006-12-07 | — | — | US | claimed |
| WO-2006124875-A2 | DIARYLSULFONE SULFONAMIDES AND USE THEROF | WYETH (US) | 2006-11-23 | — | — | WO | claimed |
| EP-1879859-A2 | DIARYLSULFONE SULFONAMIDES AND USE THEROF | Wyeth a Corporation of the State of Delaware (US) | 2008-01-23 | — | — | EP | disclosed |
| US-20060276464-A1 | Diarylsulfone sulfonamides and use thereof | WYETH (US) | 2006-12-07 | — | — | US | disclosed |
| WO-2006124875-A2 | DIARYLSULFONE SULFONAMIDES AND USE THEROF | WYETH (US) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276464-A1 | Diarylsulfone sulfonamides and use thereof | SFRP1, SOS1, FZD7 | SFRP1 1/4885HTR7 3430/4885HTR2A 4158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.